User talk:John Moffett

From Citizendium
Revision as of 12:26, 22 September 2008 by imported>John Moffett
Jump to navigation Jump to search
Citizendium Editor Policy
The Editor Role | Approval Process | Article Deletion Policy
See also: Citizendium Council | Content Policy | Help for Editors
How to Edit
Getting Started Organization Technical Help
Policies Content Policy
Welcome Page

Welcome, new editor! We're very glad you've joined us. Here are pointers for a quick start. Also, when you get a chance, please read The Editor Role. You can look at Getting Started and our help system for other introductory pages. It is also important, for project-wide matters, to join the Citizendium-L (broadcast) mailing list. Announcements are also available via Twitter. You can test out editing in the sandbox if you'd like. If you need help to get going, the forum is one option. That's also where we discuss policy and proposals. You can ask any administrator for help, too. Just put a note on their "talk" page. Again, welcome and thank you! We appreciate your willingness to share your expertise, and we hope to see your edits on Recent changes soon.

Your signature on talk pages

Hi John, just a note to help you. Please use four tildes ~~~~ after your comments on the talk page and the computer will automatically add your name with the date and time so everyone will know who said what and when. Let me know if you have any other questions. If I can't help, I can at least point you in the right direction! Thanks for helping out with the naming problem. --Matt Innis (Talk) 16:17, 26 October 2007 (CDT)

NAA page

Hello John,

I started the N-acetylaspartate page after reading the neurochemistry intro on this intriguing molecule. I have included the hypothesis on myelin synthesis. Would you like to comment or expand on that?

Pierre-Alain Gouanvic 12:00, 22 September 2008 (CDT)



Hi Pierre,

Thanks very much for getting that going. I have been really busy today, but I did want to get something started for Biology week. I'll check in latter and see if I can make some additions to the NAA page. I have also just started an N-acetylasparte website here:

[1]

I am currently working on finishing up our manuscript on an initial phase I low-dose GTA (acetate) supplementation therapy for Canavan. We are submitting to Annals of Neurology this week.

Thanks again!

Best,

John

--John Moffett 12:26, 22 September 2008 (CDT)